These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 16158750

  • 1. [Trospium chloride in the treatment of idiopathic and neurogenic detrusor overactivity].
    Mazo EB, Krivoborodov GG, Shkol'nikov ME, Babanina GA, Kozyrev SV, Korshunov ES.
    Urologiia; 2005; (4):56-9. PubMed ID: 16158750
    [Abstract] [Full Text] [Related]

  • 2. [Experience with application of trospium chloride in patients with neurogenic detrusor overactivity].
    Shvarts PG, Kadykov AS, Shvedkov VV, Timerbaeva SL, Polevaia EV, Mulach AN.
    Urologiia; 2009; (5):24-9. PubMed ID: 20213911
    [Abstract] [Full Text] [Related]

  • 3. Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients?
    Menarini M, Del Popolo G, Di Benedetto P, Haselmann J, Bödeker RH, Schwantes U, Madersbacher H, TcP128-Study Group.
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):623-32. PubMed ID: 17190372
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
    Kennelly MJ, Lemack GE, Foote JE, Trop CS.
    Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
    [Abstract] [Full Text] [Related]

  • 5. [Trospium chloride (spasmex) in the treatment of lower urinary tract symptoms in patients with neurogenic hyperactive urinary bladder caused by vertebrogenic lesions].
    Mazo EB, Babanina GA.
    Urologiia; 2007 Oct; (3):15-9. PubMed ID: 17722614
    [Abstract] [Full Text] [Related]

  • 6. Trospium chloride for the treatment of overactive bladder with urge incontinence.
    Singh-Franco D, Machado C, Tuteja S, Zapantis A.
    Clin Ther; 2005 May; 27(5):511-30. PubMed ID: 15978301
    [Abstract] [Full Text] [Related]

  • 7. [Spasmex treatment of patients with hyperactive urinary bladder].
    Pushkar' DIu, Shchaveleva OB.
    Urologiia; 2003 May; (4):46-9. PubMed ID: 12942728
    [Abstract] [Full Text] [Related]

  • 8. Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily.
    Fröhlich G, Bulitta M, Strösser W.
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):295-303. PubMed ID: 12139206
    [Abstract] [Full Text] [Related]

  • 9. [High-dose trospium chloride in therapy of detrusor hyperreflexia].
    Madersbacher H, Stöhrer M, Richter R, Giannetti BM, Mürtz G.
    Urologe A; 1991 Jul; 30(4):260-3. PubMed ID: 1926674
    [Abstract] [Full Text] [Related]

  • 10. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
    Halaska M, Ralph G, Wiedemann A, Primus G, Ballering-Brühl B, Höfner K, Jonas U.
    World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage.
    Horstmann M, Schaefer T, Aguilar Y, Stenzl A, Sievert KD.
    Neurourol Urodyn; 2006 May; 25(5):441-5. PubMed ID: 16847942
    [Abstract] [Full Text] [Related]

  • 13. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
    Palleschi G, Pastore AL, Stocchi F, Bova G, Inghilleri M, Sigala S, Carbone A.
    Clin Neuropharmacol; 2006 May; 29(4):220-9. PubMed ID: 16855424
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP, Nishiguchi J, O'Leary M, Yoshimura N, Chancellor MB.
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [Abstract] [Full Text] [Related]

  • 19. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC.
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.